Association of increased cardiorespiratory fitness with low risk for clustering of metabolic syndrome components in asymptomatic men

Archives of Medical Research
Raza H OrakzaiRaul D Santos

Abstract

From a preventive aspect, it is especially important to investigate the lifestyle risk factors associated with cardiovascular disease (CVD). The purpose of this study was to determine the relationship of increasing metabolic syndrome (MS) components across increasing levels of estimated cardiorespiratory fitness (CRF) in asymptomatic young to middle-aged men. We studied 449 consecutive asymptomatic men (47 +/- 7 years) who underwent a maximal treadmill exercise test according to the Bruce protocol. Cardiorespiratory fitness (CRF) was divided into tertiles based on metabolic equivalents (METs). The following MS components were studied: 1) waist circumference > 102 cm; 2) serum triglycerides > or = 150 mg/dL; 3) HDL cholesterol levels of < 40 mg/dL; 4) fasting blood glucose (FBG) > or = 110 mg/dL or 5) blood pressure > or = 130/85 mmHg or treated hypertension. Multinomial logistic regression was used to investigate the relationship between clustering of MS components and CRF as determined by metabolic equivalents (METs). We used polytomous logistic regression to determine the likelihood of clustering of increasing components of metabolic syndrome with intermediate (2nd tertile) and low (1st tertile) levels of CRF as compared to t...Continue Reading

References

Feb 1, 1991·Medicine and Science in Sports and Exercise·M B WallaceN R Green
Mar 1, 1987·The American Journal of Cardiology·J E HansenK Wasserman
Jul 17, 1996·JAMA : the Journal of the American Medical Association·S N BlairL W Gibbons
Mar 13, 1998·JAMA : the Journal of the American Medical Association·E J Mayer-DavisR N Bergman
Feb 17, 2000·The New England Journal of Medicine·R HambrechtG Schuler
Mar 27, 2001·Archives of Internal Medicine·J A LaukkanenJ T Salonen
Oct 3, 2002·The American Journal of Cardiology·Iftikhar J KulloThomas G Allison
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Aug 6, 2003·Medicine and Science in Sports and Exercise·Timo A LakkaJukka T Salonen
Oct 3, 2003·Medicine and Science in Sports and Exercise·Peter T KatzmarzykClaude Bouchard
Oct 28, 2003·Diabetes Care·Carlos LorenzoUNKNOWN San Antonio Heart Study

❮ Previous
Next ❯

Citations

Nov 30, 2010·Journal of the American Dietetic Association·Carrie E FinleyWilliam L Haskell
Feb 17, 2010·Metabolic Syndrome and Related Disorders·Stacey A ZenoMerrily Poth
Apr 3, 2007·Cardiovascular Diabetology·Doreen M RabiWilliam A Ghali
Dec 23, 2015·Diabetology & Metabolic Syndrome·Hee-Jin Hwang, Sang-Hwan Kim
Aug 21, 2014·Clinical Cardiology·Mouaz H Al-MallahMichael J Blaha
Sep 8, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Barbara SassenLuc Vanhees
Dec 19, 2006·Expert Review of Cardiovascular Therapy·Earl S Ford, Chaoyang Li
Aug 26, 2014·Journal of Occupational and Environmental Medicine·Wayne N BurtonHanna Abrahamsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.